MedPath

NEUTRA MAXX 5000

Approved
Approval ID

fcbe6baa-2827-49df-9316-42cc86595203

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 17, 2023

Manufacturers
FDA

Massco Dental A Division of Dunagin Pharmaceuticals

DUNS: 008081858

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM FLUORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63783-504
Product Classification
G
Generic Name
SODIUM FLUORIDE
Product Specifications
Route of AdministrationORAL
Effective DateDecember 17, 2023
FDA Product Classification

INGREDIENTS (8)

SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
SODIUM FLUORIDEActive
Quantity: 1.428 g in 120 g
Code: 8ZYQ1474W7
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
XYLITOLInactive
Code: VCQ006KQ1E
Classification: IACT
POTASSIUM NITRATEInactive
Code: RU45X2JN0Z
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUMInactive
Code: K679OBS311
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
SODIUM PHOSPHATEInactive
Code: SE337SVY37
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEUTRA MAXX 5000 - FDA Drug Approval Details